Trends show rising rates of cancers among young adults; The Physicians Foundation launches program to address social determinants of health; Blue Shield California drops CVS health
A recent study revealed an alarming trend of increasing cancer rates among younger Americans, particularly women, with certain types such as gastrointestinal, endocrine, and breast cancers seeing the fastest rise, according to The Washington Post. The study, published in JAMA Network Open, shows that while cancer rates among older adults have declined, cancers among individuals younger thab 50 years have slightly increased overall, with the most significant increases observed among those ages 30 to 39 years. Experts point out several possible reasons for this trend, including rising obesity rates; lifestyle factors such as alcohol consumption, smoking, poor sleep, and sedentary behavior; and environmental factors like exposure to pollutants and carcinogenic chemicals. Although the exact causes are not clear, researchers emphasize the need for further research to understand and address this concerning trend.
The Physicians Foundation has initiated a grant and fellowship program to address social determinants of health (SDOH) and enhance awareness and best practices among medical associations and physicians, according to Fierce Healthcare. The grant is aimed at medical associations seeking to develop resources and data collection to integrate SDOH into patient care. Up to 5 associations will receive grants of up to $75,000 each for year-long activities focused on SDOH integration. The fellowship targets new or early-career physicians who will develop and implement projects supporting SDOH understanding and integration in medical practices. The fellow will receive a stipend of $24,000 for a 12-month program.
Blue Shield of California, a nonprofit health plan provider with 4.8 million members, has announced its decision to replace CVS Health as its pharmacy benefit manager (PBM), according to Reuters. In an effort to cut drug costs for its members and navigate rising healthcare costs, Blue Shield plans to collaborate with partners including Amazon, Mark Cuban's Cost Plus Drug Company, Abarca, and Prime Therapeutics. The move is significant as it represents the first instance of a major insurer opting to replace traditional PBMs with alternative partners to negotiate drug prices and improve the affordability and accessibility of medications for its members. This decision has had an impact on CVS Health's stock value, with shares declining by 5%, and has also affected other PBM-related companies such as Cigna Group and UnitedHealth Group.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More